SCHEMBL1991352

SCHEMBL1991352

NC(=O)c1ccccc1C(=O)Nc1ccccc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.71
MEN1 O00255 5/20 0.63
KMT2A Q03164 5/20 0.63
HPGD P15428 2/20 0.63
KDM4E B2RXH2 1/20 0.63
LMNA P02545 1/20 0.63
TP53 P04637 1/20 0.63
HTT P42858 1/20 0.63
HSD17B10 Q99714 1/20 0.63
TDP1 Q9NUW8 3/20 0.61
SIRT2 Q8IXJ6 3/20 0.59
METAP2 P50579 1/20 0.59
CYP3A4 P08684 1/20 0.59
CYP2C9 P11712 1/20 0.59
ALOX12 P18054 1/20 0.59
CHRNB2 P17787 1/20 0.59
CHRNB4 P30926 1/20 0.59
CHRNA3 P32297 1/20 0.59
CHRNA4 P43681 1/20 0.59
PRKCI P41743 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1533636 1.00 ALDH1A1 (0.71) ALDH1A1MEN1KMT2AHPGDKDM4E
SCHEMBL29024967 1.00 ALDH1A1 (0.71) ALDH1A1MEN1KMT2AHPGDKDM4E
SCHEMBL437231 0.89 ALDH1A1 (0.87) ALDH1A1MEN1KMT2AHPGDKDM4E
SCHEMBL31194406 0.89 SIRT2 (0.61) ALDH1A1MEN1KMT2AHTTSIRT2
SCHEMBL11266257 0.87 ALDH1A1 (0.83) ALDH1A1MEN1KMT2AHPGDKDM4E
SCHEMBL11266259 0.87 ALDH1A1 (0.83) ALDH1A1MEN1KMT2AHPGDKDM4E
SCHEMBL31252862 0.87 CYP3A4 (0.74) ALDH1A1MEN1KMT2AHPGDKDM4E
SCHEMBL28669297 0.87 CYP3A4 (0.74) ALDH1A1MEN1KMT2AHPGDKDM4E
SCHEMBL2521357 0.87 KMT2A (0.56) ALDH1A1MEN1KMT2AHPGDKDM4E
Salicylanilide SCHEMBL6152522 0.85 MEN1 (0.83) ALDH1A1MEN1KMT2AHPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140005049-A1 ACTIVE COMPOUND COMBINATIONS ILG KERSTIN (DE) 2014-01-02 US claimed
EP-2515649-A2 ACTIVE COMPOUND COMBINATIONS Bayer Intellectual Property GmbH (DE) 2012-10-31 EP claimed
WO-2011080044-A2 ACTIVE COMPOUND COMBINATIONS BAYER CROPSCIENCE AG (DE) 2011-07-07 WO claimed
US-20110152077-A1 Active compound combinations BAYER CROPSCIENCE AG (DE) 2011-06-23 US claimed
US-20140005049-A1 ACTIVE COMPOUND COMBINATIONS ILG KERSTIN (DE) 2014-01-02 US disclosed
US-20140007297-A1 BRASSICA PLANTS WITH ALTERED ARCHITECTURE BAYER CROPSCIENCE NV (BE) 2014-01-02 US disclosed
US-8530381-B2 Active compound combinations BAYER CROPSCIENCE AG (DE) 2013-09-10 US disclosed
EP-2566318-A1 BRASSICA PLANTS WITH ALTERED ARCHITECTURE Bayer CropScience NV (BE) 2013-03-13 EP disclosed
EP-2515649-A2 ACTIVE COMPOUND COMBINATIONS Bayer Intellectual Property GmbH (DE) 2012-10-31 EP disclosed
WO-2011137998-A1 BRASSICA PLANTS WITH ALTERED ARCHITECTURE BAYER BIOSCIENCE N.V. (BE) 2011-11-10 WO disclosed
WO-2011080044-A2 ACTIVE COMPOUND COMBINATIONS BAYER CROPSCIENCE AG (DE) 2011-07-07 WO disclosed
US-20110152077-A1 Active compound combinations BAYER CROPSCIENCE AG (DE) 2011-06-23 US disclosed
US-4431667-A Imino ethers useful for controlling insect and arachnoid pests THE UPJOHN COMPANY (US) 1984-02-14 US disclosed
US-4431667-A Imino ethers useful for controlling insect and arachnoid pests THE UPJOHN COMPANY (US) 1984-02-14 US disclosed
US-4357347-A INSECTICIDES, INSECT GROWTH REGULATORS THE UPJOHN COMPANY (US) 1982-11-02 US disclosed
US-4357347-A INSECTICIDES, INSECT GROWTH REGULATORS THE UPJOHN COMPANY (US) 1982-11-02 US disclosed
US-4357347-A INSECTICIDES, INSECT GROWTH REGULATORS THE UPJOHN COMPANY (US) 1982-11-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152077-A1 Active compound combinations BROX, ATL3, AKR7A2 ALDH1A1 3621/4885MEN1 95/4885KMT2A 3664/4885
US-20140005049-A1 ACTIVE COMPOUND COMBINATIONS BROX, ATL3, AKR7A2 ALDH1A1 3621/4885MEN1 95/4885KMT2A 3664/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.